End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.17 CNY | +0.99% |
|
+2.58% | -23.40% |
06-27 | Hisun Pharmaceutical's Leukemia Drug Passes Chinese Drug Regulator's Consistency Evaluation | MT |
06-27 | Hisun Pharmaceutical's Leukemia Drug Gets Marketing Approval | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.40% | 1.16B | |
+56.09% | 816B | |
+39.36% | 634B | |
-7.55% | 351B | |
+16.30% | 323B | |
+7.32% | 293B | |
+13.13% | 238B | |
+0.78% | 222B | |
+13.22% | 218B | |
+8.11% | 167B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Hisun Pharmaceutical's Veterinary Arm Gets Nod to Produce Fenbendazole Oral Suspension